Trygve Anderson and Todd Grover discuss the sheer volume of drug price changes by sharing a macro view of Elsevier’s drug price analytics. Listen to the podcast and discover why drug compendia must be updated daily to remain current and understand how delays in pricing data can seriously affect IT, operational and financial performance. This episode is the second podcast in Elsevier’s three-part drug information series.

Host: Trygve Anderson is Elsevier’s Vice President, Commercial – Pharmacy.

Guest: Todd Grover, Co-Founder of Glass Box Analytics & President of PharmacyFocus

Learn more on Elsevier's Website

Follow on Twitter | Facebook | LinkedIn | YouTube